EZH2 regulates the expression of p16 in the nasopharyngeal cancer cells

Technology in Cancer Research and Treatment

Volumn 12, Issue 3, 2013, Pages 269-274

  Zhong, Jing ^a   Min, Lishan ^a   Huang, Huilian ^a   Li, Liqin ^a   Li, Dongli ^a   Li, Jing ^a   Ma, Zhihong ^a   Dai, Licheng ^a  

^a HUZHOU CENTRAL HOSPITAL   (China)

Author keywords

EZH2; Nasopharyngeal carcinoma (NPC); P16; Tumorigenesis

Indexed keywords

MESSENGER RNA; PROTEIN P16; SHORT HAIRPIN RNA; TRANSCRIPTION FACTOR EZH2;

ARTICLE; CANCER GROWTH; CARCINOGENESIS; CELL CYCLE; CELL PROLIFERATION; DNA METHYLATION; FLUORESCENCE ACTIVATED CELL SORTING; HUMAN; HUMAN CELL; NASOPHARYNX CANCER; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; RETROVIRUS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

EID: 84877107135     PISSN: 15330346     EISSN: None     Source Type: Journal    
DOI: 10.7785/tcrt.2012.500315     Document Type: Article

References (20)

1. Hui, A. B., Lo, K. W., Leung, S. F., Choi, P. H., Fong, Y., Lee, J. C., Huang, D. P. Loss of heterozygosity on the long arm of chromosome 11 in nasopharyngeal carcinoma. Cancer Res 56, 3225-3229 (1996).
2. Hui, A. B., Yue, S., Shi, W., Alajez, N. M., Ito, E., Green, S. R., Frame, S., O'Sullivan, B., Liu, F. F. Therapeutic effcacy of seliciclib in combination with ionizing radiation for human nasopharyngeal carcinoma. Clin Cancer Res 15, 3716-3724 (2009).
3. Tsang, Y. S., Lo, K. W., Leung, S. F., Choi, P. H., Fong, Y., Lee, J. C., Huang, D. P. Two distinct regions of deletion on chromosome 13q in primary nasopharyngeal carcinoma. Int J Cancer 83, 305-308 (1999).
4. Tong, Z. T., Cai, M. Y., Wang, X. G., Kong, L. L., Mai, S. J., Liu, Y. H., Zhang, H. B., Liao, Y. J., Zheng, F., Zhu, W., Liu, T. H., Bian, X. W., Guan, X. Y., Lin, M. C., Zeng, M. S., Zeng, Y. X., Kung, H. F., Xie, D. EZH2 supports nasopharyngeal carcinoma cell aggressiveness by forming a co-repressor complex with HDAC1/HDAC2 and Snail to inhibit E-cadherin. Oncogene 31, 583-594 (2012).
5. Xiao, Y. Enhancer of zeste homolog 2: A potential target for tumor therapy. Int J Biochem Cell Biol 43, 474-477 (2011).
6. Hwang, C. F., Huang, H. Y., Chen, C. H., Chien, C. Y., Hsu, Y. C., Li, C. F., Fang, F. M. Enhancer of zeste homolog 2 overexpression in nasopharyngeal carcinoma: an independent poor prognosticator that enhances cell growth. Int J Radiat Oncol Biol Phys 82, 597-604 (2012).
7. Lu, J., He, M. L., Wang, L., Chen, Y., Liu, X., Dong, Q., Chen, Y.C., Peng, Y., Yao, K. T., Kung, H. F., Li, X. P. MiR-26a inhibits cell growth and tumorigenesis of nasopharyngeal carcinoma through repression of EZH2. Cancer Res 71, 225-233 (2011).
8. Hwang, C. F., Cho, C. L., Huang, C. C., Wang, J. S., Shih, Y. L., Su, C. Y., Chang, H. W. Loss of cyclin D1 and p16 expression correlates with local recurrence in nasopharyngeal carcinoma following radiotherapy. Ann Oncol 13, 1246-1251 (2002).
9. Makitie, A. A., MacMillan, C., Ho, J., Shi, W., Lee, A., O'Sullivan, B., Payne, D., Pintilie, M., Cummings, B., Waldron, J., Warde, P., Irish, J., Brown, D., Gilbert, R., Gullane, P., Liu, F. F., Kamel-Reid, S. Loss of p16 expression has prognostic signifcance in human nasopharyngeal carcinoma. Clin Cancer Res 9, 2177-2184 (2003).
10. Riggi, N., Suva, M. L., Suva, D., Cironi, L., Provero, P., Tercier, S., Joseph, J. M., Stehle, J. C., Baumer, K., Kindler, V., Stamenk-ovic, I. EWS-FLI-1 expression triggers a Ewing's sarcoma initiation program in primary human mesenchymal stem cells. Cancer Res 68, 2176-2185 (2008).
11. Alajez, N. M., Mocanu, J. D., Shi, W., Chia, M. C., Breitbach, C. J., Hui, A. B., Knowles, S., Bell, J. C., Busson, P., Takada, K., Lo, K. W., O'Sullivan, B., Gullane, P., Liu, F. F. Effcacy of systemically administered mutant vesicular stomatitis virus (VSVDelta51) combined with radiation for nasopharyngeal carcinoma. Clin Cancer Res 14, 4891-4897 (2008).
12. Palmisano, W. A., Divine, K. K., Saccomanno, G., Gilliland, F. D., Baylin, S. B., Herman, J. G., Belinsky, S. A. Predicting lung cancer by detecting aberrant promoter methylation in sputum. Cancer Res 60, 5954-5958 (2000).
13. Merlo, A., Herman, J. G., Mao, L., Lee, D. J., Gabrielson, E., Burger, P. C., Baylin, S. B., Sidransky, D. 5′ CpG island methylation is associated with transcriptional silencing of the tumour suppressor p16/CDKN2/MTS1 in human cancers. Nat Med 1, 686-692 (1995).
14. Shibosawa, E., Tsutsumi, K., Koizuka, I., Hoshikawa, M., Kakakuwa, T. Absence of nuclear p16 from Epstein-Barr virus-associated undif-ferentiated nasopharyngeal carcinomas. Laryngoscope 110, 93-97 (2000).
15. Lo, K. W., Cheung, S. T., Leung, S. F., van Hasselt, A., Tsang, Y. S., Mak, K. F., Chung, Y. F., Woo, J. K., Lee, J. C., Huang, D. P. Hyper-methylation of the p16 gene in nasopharyngeal carcinoma. Cancer Res 56, 2721-2725 (1996).
16. Jacobs, J. J., Kieboom, K., Marino, S., DePinho, R. A., van Lohuizen, M. The oncogene and Polycomb-group gene bmi-1 regulates cell proliferation and senescence through the INK4a locus. Nature 397, 164-168 (1999).
17. Vire, E., Brenner, C., Deplus, R., Blanchon, L., Fraga, M., Didelot, C., Morey, L., Van Eynde, A., Bernard, D., Vanderwinden, J. M., Bollen, M., Esteller, M., Di Croce, L., de Launoit, Y., Fuks, F. The Polycomb group protein EZH2 directly controls DNA methylation. Nature 439, 871-874 (2006).
18. Allday, M. J., Kundu, D., Finerty, S., Griffn, B. E. CpG methylation of viral DNA in EBV-associated tumours. Int J Cancer 45, 1125-1130 (1990).
19. Minarovits, J., Hu, L. F., Minarovits-Kormuta, S., Klein, G., Ernberg, I. Sequence-specifc methylation inhibits the activity of the Epstein-Barr virus LMP 1 and BCR2 enhancer-promoter regions. Virology 200, 661-667 (1994).
20. Soo, R., Putti, T., Tao, Q., Goh, B. C., Lee, K. H., Kwok-Seng, L., Tan, L., Hsieh, W. S. Overexpression of cyclooxygenase-2 in nasopha-ryngeal carcinoma and association with epidermal growth factor receptor expression. Arch Otolaryngol Head Neck Surg 131, 147-152 (2005).